These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34624095)

  • 21. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. UK science advisers: publish evidence behind COVID vaccine changes.
    Nature; 2021 Jan; 589(7841):169-170. PubMed ID: 33437064
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis.
    Choi A; Koch M; Wu K; Chu L; Ma L; Hill A; Nunna N; Huang W; Oestreicher J; Colpitts T; Bennett H; Legault H; Paila Y; Nestorova B; Ding B; Montefiori D; Pajon R; Miller JM; Leav B; Carfi A; McPhee R; Edwards DK
    Nat Med; 2021 Nov; 27(11):2025-2031. PubMed ID: 34526698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the comirnaty COVID-19 vaccine in nursing home residents.
    Sánchez-Sendra B; Albert E; Zulaica J; Torres I; Giménez E; Botija P; Beltrán MJ; Rodado C; Geller R; Navarro D
    Sci Rep; 2022 Mar; 12(1):3788. PubMed ID: 35260713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [SARS-CoV-2 vaccines].
    Benfield TL; Helweg-Larsen J
    Ugeskr Laeger; 2021 Mar; 183(10):. PubMed ID: 33734065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viewpoint of the European Pediatric Societies over Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination in Children Younger Than Age 12 Years Amid Return to School and the Surging Virus Variants.
    Pettoello-Mantovani M; Carrasco-Sanz A; Huss G; Mestrovic J; Vural M; Pop TL; Ferrara P; Somekh E; Mujkic A; Hoey H; Namazova-Baranova L
    J Pediatr; 2021 Dec; 239():250-251.e2. PubMed ID: 34536493
    [No Abstract]   [Full Text] [Related]  

  • 27. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study.
    Li XN; Huang Y; Wang W; Jing QL; Zhang CH; Qin PZ; Guan WJ; Gan L; Li YL; Liu WH; Dong H; Miao YT; Fan SJ; Zhang ZB; Zhang DM; Zhong NS
    Emerg Microbes Infect; 2021 Dec; 10(1):1751-1759. PubMed ID: 34396940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.
    He X; Ding L; Cao K; Peng H; Gu C; Li Y; Li D; Dong L; Hong X; Wang X; Fu M; Qiu C; Zhu C; Zhang Z; Song S; Wang C; Jiang Z; Xie Y; Qi Z; Zhao C; Zhao P; Zhang X; Xu J
    Emerg Microbes Infect; 2021 Dec; 10(1):1555-1573. PubMed ID: 34304724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in the case fatality risks associated with SARS-CoV-2 Delta and non-Delta variants in relation to vaccine coverage: An early ecological study in the United Kingdom.
    Zhao S; Lou J; Cao L; Chong KC; Zee BCY; Chan PKS; Wang MH
    Infect Genet Evol; 2022 Jan; 97():105162. PubMed ID: 34843993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Why Oxford's positive COVID vaccine results are puzzling scientists.
    Callaway E
    Nature; 2020 Dec; 588(7836):16-18. PubMed ID: 33230278
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral Vaccination Protects Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Syrian Hamster Challenge Model.
    Johnson S; Martinez CI; Tedjakusuma SN; Peinovich N; Dora EG; Birch SM; Kajon AE; Werts AD; Tucker SN
    J Infect Dis; 2022 Jan; 225(1):34-41. PubMed ID: 34758086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Audio Interview: New Evidence on SARS-CoV-2 Vaccine Boosters.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Sep; 385(12):e48. PubMed ID: 34525292
    [No Abstract]   [Full Text] [Related]  

  • 35. What scientists do and don't know about the Oxford-AstraZeneca COVID vaccine.
    Mallapaty S; Callaway E
    Nature; 2021 Apr; 592(7852):15-17. PubMed ID: 33762708
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
    Sharif N; Alzahrani KJ; Ahmed SN; Dey SK
    Front Immunol; 2021; 12():714170. PubMed ID: 34707602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination of Pregnant Women Against COVID-19.
    Abu-Raya B
    Neoreviews; 2021 Sep; 22(9):e570-e573. PubMed ID: 34470758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera.
    Muik A; Wallisch AK; Sänger B; Swanson KA; Mühl J; Chen W; Cai H; Maurus D; Sarkar R; Türeci Ö; Dormitzer PR; Şahin U
    Science; 2021 Mar; 371(6534):1152-1153. PubMed ID: 33514629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape.
    Tregoning JS; Flight KE; Higham SL; Wang Z; Pierce BF
    Nat Rev Immunol; 2021 Oct; 21(10):626-636. PubMed ID: 34373623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19.
    Li Q; Wang J; Tang Y; Lu H
    Drug Discov Ther; 2021; 15(3):118-123. PubMed ID: 34234059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.